Marksans Pharma Limited — Others, 25-06-2025: Trading Window

Marksans Pharma has announced a board meeting to discuss the financial results for the quarter and half-year. The trading window for designated persons will be closed starting July 1, 2025, until 48 hours after these results are declared. This halt restricts insiders and their immediate relatives from trading the company’s shares during this sensitive period, ensuring compliance with internal trading policies and maintaining market integrity.